granted
on 12 Sep 2024
Last Applicant/ Owned by
6055 Lusk Blvd.
San Diego
CA
92121
Serial Number
97844252 filed on 17th Mar 2023
Registration Number
N/A
Correspondent Address
Danny M. Awdeh
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Medical research services; scientific research and development; pharmaceutical research and development; therapeutic research and development, namely, research and development of therapeutic preparations; research and development in the field of oncology; medical research for treating cancer, endocrine disorders, acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, chronic pain, Read More
Medical research services; scientific research and development; pharmaceutical research and development; therapeutic research and development, namely, research and development of therapeutic preparations; research and development in the field of oncology; medical research for treating cancer, endocrine disorders, acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, chronic pain, hypercalcemia, hyperparathyroidism, polycystic kidney disease, Grave's disease, thyroid eye disease, thyroid ophthalmopathy, diabetes, obesity, insulinoma, hypoglycemia, androgen deficiency, infertility, thyroid cancer, growth hormone deficiency, hypoparathyroidism, nonfunctional pituitary adenomas, polycystic liver disease, and type two diabetes; pharmaceutical research for treating cancer, endocrine disorders, acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain, hypercalcemia, hyperparathyroidism, polycystic kidney disease, Grave's disease, thyroid eye disease, thyroid ophthalmopathy, diabetes, obesity, insulinoma, hypoglycemia, androgen deficiency, infertility, thyroid cancer, growth hormone deficiency, hypoparathyroidism, nonfunctional pituitary adenomas, polycystic liver disease, and type two diabetes; therapeutic research, namely, research of therapeutic preparations for ocular diseases and disorders, metabolic diseases and disorders, hormonal diseases and disorders, reproductive diseases and disorders, bone diseases and disorders, digestive diseases and disorders, gastroenterological diseases and disorders, and thyroid diseases and disorders; providing medical and scientific research information in the fields of pharmaceuticals and therapeutics
N/A
N/A
Pharmaceutical preparations for modulating neuropeptides and G-protein coupled receptors (GPCRs); pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in treating endocrine disorders and endocrine related diseases; pharmaceutical preparations for targeting neuropeptide receptors; pharmaceutical preparations for the treatment of cancer, acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, carcinoid syndrome, congenital adrenal hyperplasia, hypercalcemia, chronic pain, hyperparathyroidism, polycystic kidney disease, Grave's disease, thyroid eye disease, thyroid ophthalmopathy, diabetes, obesity, insulinoma, hypoglycemia, androgen deficiency, infertility, thyroid cancer, growth hormone deficiency, hypoparathyroidism, nonfunctional pituitary adenomas, polycystic liver disease, and type two diabetes; therapeutic preparations for the treatment of ocular diseases and disorders, metabolic diseases and disorders, hormonal diseases and disorders, reproductive diseases and disorders, bone diseases and disorders, digestive diseases and disorders, gastroenterological diseases and disorders, and thyroid diseases and disorders
N/A
N/A
No 97844252
No Service Mark
No 16187.0009
No
No
No
No
No
No
No
No
26.01.06 -
Semi-circles
26.01.26 -
Spirals, coils and swirls
26.17.25 -
Other lines, bands or bars
Status Date | Action Taken |
---|---|
12th Sep 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
12th Sep 2024 | SOU EXTENSION 1 GRANTED |
12th Sep 2024 | SOU EXTENSION 1 FILED |
12th Sep 2024 | SOU TEAS EXTENSION RECEIVED |
12th Sep 2024 | TEAS STATEMENT OF USE RECEIVED |
26th Mar 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
28th Feb 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
28th Feb 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
28th Feb 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
30th Jan 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |